Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0048 | 0.1486 | 0.5 |
Trypanosoma brucei | trypanothione reductase | 0.0137 | 0.5731 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0048 | 0.1486 | 1 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0058 | 0.1962 | 0.1962 |
Echinococcus granulosus | glutamate receptor 2 | 0.0024 | 0.0392 | 0.0392 |
Plasmodium vivax | glutathione reductase, putative | 0.0137 | 0.5731 | 1 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0048 | 0.1486 | 0.0639 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0058 | 0.1962 | 0.1962 |
Echinococcus granulosus | glutamate receptor ionotrophic AMPA 3 | 0.0024 | 0.0392 | 0.0392 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0048 | 0.1486 | 0.1486 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0825 | 0.0825 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0048 | 0.1486 | 0.5 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0048 | 0.1486 | 0.0639 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0228 | 1 | 1 |
Echinococcus multilocularis | glutamate receptor, ionotrophic, AMPA 3 | 0.0024 | 0.0392 | 0.0392 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0039 | 0.1066 | 0.1066 |
Plasmodium falciparum | thioredoxin reductase | 0.0137 | 0.5731 | 1 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0024 | 0.0392 | 0.0392 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0048 | 0.1486 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0048 | 0.1486 | 1 |
Treponema pallidum | NADH oxidase | 0.0048 | 0.1486 | 1 |
Brugia malayi | glutathione reductase | 0.0137 | 0.5731 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0024 | 0.0392 | 0.0392 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0048 | 0.1486 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0042 | 0.1235 | 0.1235 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0137 | 0.5731 | 0.5731 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0048 | 0.1486 | 0.0639 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0024 | 0.0392 | 0.0392 |
Brugia malayi | hypothetical protein | 0.0105 | 0.4184 | 0.7301 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0035 | 0.0888 | 0.155 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0024 | 0.0392 | 0.0392 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0048 | 0.1486 | 0.0639 |
Brugia malayi | Thioredoxin reductase | 0.0137 | 0.5731 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0058 | 0.1962 | 0.1962 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0137 | 0.5731 | 1 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0039 | 0.1066 | 0.1861 |
Echinococcus multilocularis | glutamate receptor 2 | 0.0024 | 0.0392 | 0.0392 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0137 | 0.5731 | 0.5731 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0035 | 0.0888 | 0.155 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0039 | 0.1066 | 0.1066 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0048 | 0.1486 | 0.1486 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0039 | 0.1066 | 0.1066 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 2 | 0.0024 | 0.0392 | 0.0392 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0048 | 0.1486 | 0.1486 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0137 | 0.5731 | 1 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0137 | 0.5731 | 0.5731 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0042 | 0.1235 | 0.1235 |
Loa Loa (eye worm) | glutathione reductase | 0.0137 | 0.5731 | 0.5731 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0048 | 0.1486 | 0.2593 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0048 | 0.1486 | 0.5 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0048 | 0.1486 | 1 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0024 | 0.0392 | 0.0392 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0048 | 0.1486 | 1 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0228 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0048 | 0.1486 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0137 | 0.5731 | 1 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0228 | 1 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0137 | 0.5731 | 1 |
Leishmania major | trypanothione reductase | 0.0137 | 0.5731 | 1 |
Echinococcus granulosus | Glutamate receptor ionotropic kainate 2 | 0.0024 | 0.0392 | 0.0392 |
Toxoplasma gondii | thioredoxin reductase | 0.0137 | 0.5731 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Concentration (functional) | = 1 % | Concentration causing local anesthetic activity in mice | ChEMBL. | 3184128 |
IC50 (binding) | = 3 uM | Inhibition of [3H]-nitrendipine binding to calcium channels in Rabbit cardiac muscle. | ChEMBL. | 3184128 |
Inhibition (functional) | = 50 % | Percent inhibition of calcium-dependent potassium-polarized smooth muscle contraction in canine trachea | ChEMBL. | 3184128 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.